Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 43

Sort by

Sort Order Select

Journal Articles

Abstract 7248: Expression profiles of 10 common cancer-specific antigens collected for the development of cancer vaccines and T cell therapies applicable to most solid cancer patients

Tetsuya Nakatsura, Kazumasa Takenouchi, Jun Kataoka, Yusuke Ito, Sae Kikuchi, Hiroki Kinoshita, Kazunobu Ohnuki, Toshihiro Suzuki, Nobuo Tsukamoto

Cancer Res (2025) 85 (8_Supplement_1): 7248.

https://doi.org/10.1158/1538-7445.AM2025-7248

Published: 21 April 2025

View articletitled, Abstract 7248: Expression profiles of 10 common cancer-specific antigens collected for the development of cancer vaccines and T cell therapies applicable to most solid cancer patients

Journal Articles

Abstract 3614: T cell receptor-engineered T cell therapy using TCR gene derived from an HLA-A2 hepatoblastoma patient who was completely cured by administration of glypican-3 peptide vaccine

Tsuyoshi Terada, Kazunobu Ohnuki, Manami Shimomura, Toshihiro Suzuki, Yasunori Amaishi, Kaho Takeichi, Sachiko Okamoto, Norihiro Fujinami, Kazumasa Takenouchi, Nobuo Tsukamoto, Kayoko Shoda, Toshiaki Yoshikawa, Tetsuya Nakatsura

Cancer Res (2024) 84 (6_Supplement): 3614.

https://doi.org/10.1158/1538-7445.AM2024-3614

Published: 22 March 2024

View articletitled, Abstract 3614: T cell receptor-engineered T cell therapy using TCR gene derived from an HLA-A2 hepatoblastoma patient who was completely cured by administration of glypican-3 peptide vaccine

Journal Articles

Abstract 5010: Development of a universal cancer vaccine using common cancer antigens cocktail that targets various cancer patients and overcomes the heterogeneity of individual cancer

Tetsuya Nakatsura, Kazumasa Takenouchi, Hiroki Kinoshita, Nobuo Tsukamoto, Kazunobu Ohnuki, Toshihiro Suzuki

Cancer Res (2024) 84 (6_Supplement): 5010.

https://doi.org/10.1158/1538-7445.AM2024-5010

Published: 22 March 2024

View articletitled, Abstract 5010: Development of a universal cancer vaccine using common cancer antigens cocktail that targets various cancer patients and overcomes the heterogeneity of individual cancer

Journal Articles

Abstract 5185: First in human trial of off-the shelf iPS derived anti-GPC3 NK cells for recurrent ovarian clear cell carcinoma with peritoneal dissemination

Cancer Res (2022) 82 (12_Supplement): 5185.

https://doi.org/10.1158/1538-7445.AM2022-5185

Published: 15 June 2022

View articletitled, Abstract 5185: First in human trial of off-the shelf iPS derived anti-GPC3 NK cells for recurrent ovarian clear cell carcinoma with peritoneal dissemination

Journal Articles

Abstract 6143: Tumor immune microenvironment in salivary gland cancer

Yoshiaki Nagatani, Naomi Kiyota, Yoshinori Imamura, Taiji Koyama, Yohei Funakoshi, Masato Komatsu, Masanori Teshima, Ken-Ichi Nibu, Kazuko Sakai, Kazuto Nishio, Manami Shimomura, Tetsuya Nakatsura, Daiki Ikarashi, Takayuki Nakayama, Shigehisa Kitano, Hironobu Minami

Cancer Res (2022) 82 (12_Supplement): 6143.

https://doi.org/10.1158/1538-7445.AM2022-6143

Published: 15 June 2022

View articletitled, Abstract 6143: Tumor immune microenvironment in salivary gland cancer

Journal Articles

Abstract 6389: A novel computational pipeline supported with in vivo vaccination models for identification and validation of neoantigens

Kazushi Hiranuka, Keigo Takahashi, Dave Tang, Noriko Watanabe, Takashi Yamada, Yuji Mishima, Norihiro Fujinami, Manami Shimomura, Toshihiro Suzuki, Tetsuya Nakatsura, Norihiro Nakamura

Cancer Res (2022) 82 (12_Supplement): 6389.

https://doi.org/10.1158/1538-7445.AM2022-6389

Published: 15 June 2022

View articletitled, Abstract 6389: A novel computational pipeline supported with in vivo vaccination models for identification and validation of neoantigens

Journal Articles

Abstract 3552: Personalized neoantigen cancer vaccine assembled on DC targeting antibody improves cancer immunity

Yuji Mishima, Fumiko Isoda, Noriko Matsumoto, Noriko Watanabe, Kazushi Hiranuka, Takashi Yamada, Norihiro Fujinami, Manami Shimomura, Toshihiro Suzuki, Tetsuya Nakatsura, Norihiro Nakamura

Cancer Res (2022) 82 (12_Supplement): 3552.

https://doi.org/10.1158/1538-7445.AM2022-3552

Published: 15 June 2022

View articletitled, Abstract 3552: Personalized neoantigen cancer vaccine assembled on DC targeting antibody improves cancer immunity

Journal Articles

Abstract LB-019: Anti-CD4 monoclonal antibody immunotherapy exerts an antitumor effect by replacing the T cell receptor repertoire in patients with gastrointestinal cancer

Cancer Res (2019) 79 (13_Supplement): LB-019.

https://doi.org/10.1158/1538-7445.AM2019-LB-019

Published: 01 July 2019

View articletitled, Abstract LB-019: Anti-CD4 monoclonal antibody immunotherapy exerts an antitumor effect by replacing the T cell receptor repertoire in patients with gastrointestinal cancer

Journal Articles

Abstract 1432: Enhanced effector responses of regenerated CAR-T cells derived from genome edited iPSCs

Tatsuki Ueda, Shoichi Iriguchi, Yohei Kawai, Atsutaka Minagawa, Hiroyuki Miyoshi, Seitaro Terakura, Yasushi Uemura, Knut Woltjen, Yuzo Kodama, Hiroshi Seno, Yasumichi Hitoshi, Tetsuya Nakatsura, Koji Tamada, Shin Kaneko

Cancer Res (2019) 79 (13_Supplement): 1432.

https://doi.org/10.1158/1538-7445.AM2019-1432

Published: 01 July 2019

View articletitled, Abstract 1432: Enhanced effector responses of regenerated CAR-T cells derived from genome edited iPSCs

Journal Articles

Abstract 2550: Generation of CAR-iPS-T cells expressing CD8β

Cancer Res (2018) 78 (13_Supplement): 2550.

https://doi.org/10.1158/1538-7445.AM2018-2550

Published: 01 July 2018

View articletitled, Abstract 2550: Generation of CAR-iPS-T cells expressing CD8β

Journal Articles

Abstract 3585: T cell receptor-stabilized regenerated CD8ab cytotoxic T lymphocytes for cancer immunotherapy

Atsutaka Minagawa, Akitsu Hotta, Yohei Kawai, Yutaka Yasui, Yasushi Uemura, Masaki Yasukawa, Tetsuya Nakatsura, Shin Kaneko

Cancer Res (2018) 78 (13_Supplement): 3585.

https://doi.org/10.1158/1538-7445.AM2018-3585

Published: 01 July 2018

View articletitled, Abstract 3585: T cell receptor-stabilized regenerated CD8ab cytotoxic T lymphocytes for cancer immunotherapy

Journal Articles

Abstract 846: A novel high-throughput 3D screening system for EMT inhibitors

Kazuya Arai, M Mamunur Rahman, Manabu Itoh, Norio Masuda, Takanori Eguchi, Tetsuya Nakatsura, Stuart K. Calderwood

Cancer Res (2017) 77 (13_Supplement): 846.

https://doi.org/10.1158/1538-7445.AM2017-846

Published: 01 July 2017

View articletitled, Abstract 846: A novel high-throughput 3D screening system for EMT inhibitors

Journal Articles

Abstract CT115: Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients

Yu Sawada, Toshiaki Yoshikawa, Kazuya Ofuji, Mayuko Yoshimura, Nobuhiro Tsuchiya, Mari Takahashi, Daisuke Nobuoka, Shoichi Mizuno, Itaru Endo, Tetsuya Nakatsura

Cancer Res (2015) 75 (15_Supplement): CT115.

https://doi.org/10.1158/1538-7445.AM2015-CT115

Published: 01 August 2015

View articletitled, Abstract CT115: Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients

Journal Articles

Abstract 5018: HLA class I expression in a tumor is higher than that out of a tumor: Promising new findings for antigen-specific cancer immunotherapy

Daisule Nobuoka, Mari Takahashi, Toshiaki Yoshikawa, Takahito Yagi, Toshiyoshi Fujiwara, Tetsuya Nakatsura

Cancer Res (2015) 75 (15_Supplement): 5018.

https://doi.org/10.1158/1538-7445.AM2015-5018

Published: 01 August 2015

View articletitled, Abstract 5018: HLA class I expression in a tumor is higher than that out of a tumor: Promising new findings for antigen-specific cancer immunotherapy

Journal Articles

Abstract 2503: Efficient crosspresentation of oncofetal antigen (Glypican-3)-derived long peptides encompassing CTL and promiscuous Th cell epitopes using a novel liposome

Mohammad A. Sayem, Yusuke Tomita, Akira Yuno, Masatoshi Hirayama, Atsushi Irie, Hirotake Tsukamoto, Satoru Senju, Eiji Yuba, Toshiaki Yoshikawa, Kenji Kono, Tetsuya Nakatsura, Yasuharu Nishimura

Cancer Res (2015) 75 (15_Supplement): 2503.

https://doi.org/10.1158/1538-7445.AM2015-2503

Published: 01 August 2015

View articletitled, Abstract 2503: Efficient crosspresentation of oncofetal antigen (Glypican-3)-derived long peptides encompassing CTL and promiscuous Th cell epitopes using a novel liposome

Journal Articles

Abstract 573: Glypican-3 is a predictive marker for recurrence of hepatocellular carcinoma after surgical resection, especially in early stage

Kazuya Ofuji, Keigo Saito, Yasunari Nakamoto, Tetsuya Nakatsura

Cancer Res (2015) 75 (15_Supplement): 573.

https://doi.org/10.1158/1538-7445.AM2015-573

Published: 01 August 2015

View articletitled, Abstract 573: Glypican-3 is a predictive marker for recurrence of hepatocellular carcinoma after surgical resection, especially in early stage

Journal Articles

Abstract CT219: Clinical and immunological analysis in a phase II trial of the glypican-3 peptide vaccine for patients with ovarian clear cell carcinoma

Shiro Suzuki, Kiyosumi Shibata, Fumitaka Kikkawa, Tetsuya Nakatsura

Cancer Res (2015) 75 (15_Supplement): CT219.

https://doi.org/10.1158/1538-7445.AM2015-CT219

Published: 01 August 2015

View articletitled, Abstract CT219: Clinical and immunological analysis in a phase II trial of the glypican-3 peptide vaccine for patients with ovarian clear cell carcinoma

Journal Articles

Abstract 329: Establishment of three-dimensional primary tumor cell culture method and novel drug sensitivity test

Hiroshi Goji, Manami Shimomura, Yasushi Uemura, Tetsuya Nakatsura, M.Mamunur Rahman, Manabu Itoh

Cancer Res (2015) 75 (15_Supplement): 329.

https://doi.org/10.1158/1538-7445.AM2015-329

Published: 01 August 2015

View articletitled, Abstract 329: Establishment of three-dimensional primary tumor cell culture method and novel drug sensitivity test

Journal Articles

Abstract 319: Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer

Yoshinori Imamura, Toru Mukohara, Yohei Shimono, Yohei Funakoshi, Naoko Chayahara, Masanori Toyoda, Naomi Kiyota, Shintaro Takao, Seishi Kono, Tetsuya Nakatsura, Hironobu Minami

Cancer Res (2015) 75 (15_Supplement): 319.

https://doi.org/10.1158/1538-7445.AM2015-319

Published: 01 August 2015

View articletitled, Abstract 319: Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer

Journal Articles

Abstract 1083: Host-tumor immune response for early breast cancer patients treated with radiofrequency ablation therapy

Shigeru Imoto, Noriko Nakatsugawa, Takayuki Ueno, Hiroki Ito, Kentaro Imi, Kaisuke Miyamoto, Manami Kitamura, Hirotsugu Isaka, Tetsuya Nakatsura

Cancer Res (2014) 74 (19_Supplement): 1083.

https://doi.org/10.1158/1538-7445.AM2014-1083

Published: 01 October 2014

View articletitled, Abstract 1083: Host-tumor immune response for early breast cancer patients treated with radiofrequency ablation therapy

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 7248: Expression profiles of 10 common cancer-specific antigens collected for the development of cancer vaccines and T cell therapies applicable to most solid cancer patients

Abstract 3614: T cell receptor-engineered T cell therapy using TCR gene derived from an HLA-A2 hepatoblastoma patient who was completely cured by administration of glypican-3 peptide vaccine

Abstract 5010: Development of a universal cancer vaccine using common cancer antigens cocktail that targets various cancer patients and overcomes the heterogeneity of individual cancer

Abstract 5185: First in human trial of off-the shelf iPS derived anti-GPC3 NK cells for recurrent ovarian clear cell carcinoma with peritoneal dissemination

Abstract 6143: Tumor immune microenvironment in salivary gland cancer

Abstract 6389: A novel computational pipeline supported with in vivo vaccination models for identification and validation of neoantigens

Abstract 3552: Personalized neoantigen cancer vaccine assembled on DC targeting antibody improves cancer immunity

Abstract LB-019: Anti-CD4 monoclonal antibody immunotherapy exerts an antitumor effect by replacing the T cell receptor repertoire in patients with gastrointestinal cancer

Abstract 1432: Enhanced effector responses of regenerated CAR-T cells derived from genome edited iPSCs

Abstract 2550: Generation of CAR-iPS-T cells expressing CD8β

Abstract 3585: T cell receptor-stabilized regenerated CD8ab cytotoxic T lymphocytes for cancer immunotherapy

Abstract 846: A novel high-throughput 3D screening system for EMT inhibitors

Abstract CT115: Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients

Abstract 5018: HLA class I expression in a tumor is higher than that out of a tumor: Promising new findings for antigen-specific cancer immunotherapy

Abstract 2503: Efficient crosspresentation of oncofetal antigen (Glypican-3)-derived long peptides encompassing CTL and promiscuous Th cell epitopes using a novel liposome

Abstract 573: Glypican-3 is a predictive marker for recurrence of hepatocellular carcinoma after surgical resection, especially in early stage

Abstract CT219: Clinical and immunological analysis in a phase II trial of the glypican-3 peptide vaccine for patients with ovarian clear cell carcinoma

Abstract 329: Establishment of three-dimensional primary tumor cell culture method and novel drug sensitivity test

Abstract 319: Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer

Abstract 1083: Host-tumor immune response for early breast cancer patients treated with radiofrequency ablation therapy

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only